- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Health Bulletin 22/February/2022 - Video
Overview
Here are the Top health stories of the day
Madras HC gives preference to community's Tamil LGBTQIA+ Glossary over state govt's; lauds state govt's efforts
NEET PG candidate can't claim admissions to 2021-2022 based on 2019 rank which got vitiated due to caste certificate discrepancy: Supreme Court
Experts warn of another Covid strain. BA.2 subvariant
CORBEVAX gets emergency use authorisation for 12-18 age group
Biological E. Limited has announced that its CORBEVAX vaccine, which is India's first indigenously developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against COVID-19, has received emergency use authorisation (EUA) from India's drug regulator for the 12 to 18-year age group.
The Drugs Controller General of India (DCGI) has already approved CORBEVAX for restricted use in emergency situation among adults on December 28, 2021. BE received the approval for restricted use in an emergency situation in adolescents aged 12 to less than 18 years based on interim results (of the ongoing phase II/III clinical study).
For more information, check out the full story on the link below:
Biological E Corbevax Gets DCGI Nod For 12-18 Years
Fake drug racket: Quacks selling counterfeit drugs in name of 'Ayurveda', arrested
Quacks of Andhra Pradesh are reported to be promoting fake drugs claiming to cure chronic diseases and are targetting people to sell and make easy money.
As per a media report in the Deccan Chronicle, many people claim that these quacks are ayurvedic practitioners, who can cure chronic illnesses like knee and joint pains, blood pressure, and blood sugar as also diseases affecting the liver, heart, kidneys, lungs. The people who claim to be practitioners used to set up makeshift tents in public places and in mobile vehicles with a public announcement mechanism in place.
For more information, check out the full story on the link below:
Fake Drug Racket: Quacks Selling Counterfeit Drugs In Name Of 'Ayurveda', Arrested